Health And Fitness

HEALTH TALK: Cervical Cancer – What You Need To Know

HEALTH TALK: Cervical Cancer – What You Need To Know

Globally, cervical cancer is the fourth most common cancer in women. However, in low-income countries like Uganda, the incidence shoots upwards, owing to the constrained efforts at timely HPV screening.

In Uganda, cervical cancer ranks number one as the leading cause of cancer deaths among women, most of whom present late in their course of disease to the health facilities.

The country has a population of 12.3 million women ages 15 years and older who are at risk of developing cervical cancer. Current estimates indicate that every year 6959 women are diagnosed with cervical can- cer and 4607 die from the disease.

Cause

HPV (Human Papilloma Virus), a sexually transmitted virus, is the cause of cervical cancer. It has been detected in up to 99.7% of the cancers and more than 80% of sexually active men and women worldwide are at risk of contracting it. Uganda’s HPV prevalence among women currently stands at 33.6%.

It is important for both men and women to understand the roles they play in both the spread and mitigation of these numbers. It is vital for boys and men to understand that this is not a “women problem”. Ditto for the women.

Risk factors

One of the leading risk factors for cervical cancer is early sexual debut and first birth. Women whose first sexual encounter happened before 18 years are twice more likely to test positive later in life compared to those whose first encounter happened after 21.

Having multiple sexual partners, a history of STIs or HIV, smoking and low social-economic status are among a long list of other risk factors.

Constrained efforts

The last one is quite important in understanding the epidemiology of the disease in Uganda. This is because it constrains a key pressure point in the efforts to reduce mortality rates i.e. early screening. This is where we struggle as developing nations due to inadequate resources and infrastructure.

Early screening is of utmost importance because it allows for effective identification and treatment of cervical precancerous lesions and early disease.

At the moment, screening is conducted opportunistically using VIA and is targeted for women aged 25-49 at a 3-year interval for HIV-negative women and every year for HIV-positive women.

Vaccination

Another key pressure point is vaccination against HPV which was launched in 2015 and has since been integrated in the routine Uganda National Expanded Program on Immunization.

However, uptake of vaccination processes has been quite low, even as low as 17.61% (Lira District, Northern Uganda, 2018).

It is an uphill battle and everyone has a role to play: men, women, government and civil society organizations.

Final thoughts

Key questions we have to ask ourselves are; – Why is our HPV prevalence rate high and how can we bring it down? Why is vaccination uptake still low and can policy be directed towards expanding this bottle-neck? And more importantly, how can we involve everyone in this fight?

Osbert Mwesigye
Author
Osbert Mwesigye